Burton G. Malkiel, Director at Theravance Biopharma, Inc. (TBPH), bought 15,000 shares at $24.59 ($369K) on 2017-08-11, disclosed to the SEC on 2017-08-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |